A joint clinical research by the UAE and Japan aims to offer advanced treatment options for people with diabetes. Abu Dhabi Stem Cells Centre (ADSCC) has teamed up with Kyoto University and Japanese biotech company Rege Nephro to transform diabetes care. Their collaborative effort focuses on creating a groundbreaking treatment using pancreatic beta cells from human induced pluripotent stem cells (iPS cells). These cells, obtained from skin or blood, are reprogrammed (genetically modified) in highly advanced laboratories to create cells replicating the tissue affected by diabetes.